Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer (SITC) is the world''s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.